Hemodynamic effects of BTS 49465, a new long-acting systemic vasodilator drug, in patients with severe congestive heart failure

Packer, 1983, Vasodilator and inotropic therapy for severe chronic heart failure: Passion and skepticism, J Am Coll Cardiol, 2, 841, 10.1016/S0735-1097(83)80230-7 Chatterjee, 1976, Oral hydralazine therapy for chronic refractory heart failure, Circulation, 54, 879, 10.1161/01.CIR.54.6.879 Franciosa, 1981, Effects of minoxidil on hemodynamics in patients with congestive heart failure, Circulation, 63, 652, 10.1161/01.CIR.63.3.652 Franciosa, 1974, Hemodynamic effects of orally administered isosorbide dinitrate in patients with congestive heart failure, Circulation, 50, 1020, 10.1161/01.CIR.50.5.1020 Guiha, 1974, Treatment of refractory heart failure with infusion of nitroprusside, N Engl J Med, 291, 587, 10.1056/NEJM197409192911201 Awan, 1981, Cardiocirculatory and myocardial energetic effects of prostaglandin E1 in severe left ventricular failure due to coronary heart disease, Am Heart J, 102, 703, 10.1016/0002-8703(81)90095-8 Packer, 1983, Hemodynamic patterns of response during long-term captopril therapy for severe chronic heart failure, Circulation, 68, 803, 10.1161/01.CIR.68.4.803 Cody, 1982, Renin-sodium mechanisms in chronic heart failure: Response to sodium balance studies (abstr), Circulation, 66, 11 Packer, 1982, Pharmacologic and physiologic determinants of vasodilator response. A conceptual framework for rational drug therapy for chronic heart failure, Prog Cardiovasc Dis, 24, 275, 10.1016/0033-0620(82)90006-8 Packer, 1982, Selection of vasodilator drugs for patients with severe chronic heart failure: An approach based on a new classification, Drugs, 24, 64, 10.2165/00003495-198224010-00003 Sim, 1984, BTS 49465—A novel hypotensive agent Cowley, 1984, The effects of BTS 49465 in blood pressure and peripheral arteriolar and venous tone in normal volunteers, J Hypertension, 2, 547 Wynne, 1985, The pharmacokinetics and haemodynamics of BTS 49465 and its major metabolite in healthy volunteers, Eur J Clin Pharmacol, 28, 659, 10.1007/BF00607911 Packer, 1985, Hemodynamic changes mimicking a vasodilator drug response in the absence of drug therapy after right heart catheterization in patients with chronic he, Circulation, 71, 761, 10.1161/01.CIR.71.4.761 Packer, 1980, Hemodynamic evaluation of hydralazine dosage in refractory heart failure, Clin Pharmacol Ther, 27, 337, 10.1038/clpt.1980.45 Packer, 1980, Dose requirements of hydralazine in patients with severe chronic congestive heart failure, Am J Cardiol, 45, 655, 10.1016/S0002-9149(80)80019-1 Packer, 1981, Determinats of drug response in severe chronic heart failure. I. Activation of vasoconstrictor forces during vasodilator therapy, Circulation, 64, 506, 10.1161/01.CIR.64.3.506 Packer, 1979, Differences in the hemodynamic effects of nitroprusside and prazosin in severe chronic heart failure. Evidence for a direct negative chronotropic effect of prazosin, Am J Cardiol, 44, 310, 10.1016/0002-9149(79)90322-9 Packer, 1982, Contrasting hemodynamic responses in severe heart failure: Comparison of captopril and other vasodilator drugs, Am Heart J, 104, 1215, 10.1016/0002-8703(82)90054-0 Pagani, 1978, Hemodynamic effects of intravenous nitroprusside in the conscious dog, Circulation, 57, 144, 10.1161/01.CIR.57.1.144 Cohn, 1978, Contrasting effect of vasodilators on heart rate and plasma catecholamines in patients with hypertenson and heart failure (abstr), Clin Res, 26, 547A Packer, 1979, Rebound hemodynamic events after the abrupt withdraval of nitroprusside in patients with severe chronic heart failure, N Engl J Med, 301, 1193, 10.1056/NEJM197911293012201 Higgins, 1972, Alterations in the baroreceptor reflex in conscious dogs with heart failure, J Clin Invest, 51, 715, 10.1172/JCI106865 Gellhorn, 1964, The significance of the state of the central autonomic nervous system for quantitative and qualitative aspects of some cardiovascular reactions, Am Heart J, 67, 106, 10.1016/0002-8703(64)90406-5 Chidsey, 1965, Catecholamine excretion and cardiac stores of norepinephrine in congestive heart failure, Am J Med, 39, 442, 10.1016/0002-9343(65)90211-1 Kramer, 1968, Augmented sympathetic neurotransmitter activity in the peripheral vascular bed of patients with congestive heart failure and cardiac norepinephrine depletion, Circulation, 38, 629, 10.1161/01.CIR.38.4.629 Ueda, 1968, Hydralazine and plasma renin activity, Arch Intern Med, 122, 387, 10.1001/archinte.1968.00040010387001 Fitchett, 1979, Hydralazine in the management of left ventricular failure, Am J Cardiol, 44, 303, 10.1016/0002-9149(79)90321-7 Packer, 1983, Quantitative differences in the hemodynamic effects of captopril and nitroprusside in severe chronic heart failure, Am J Cardiol, 51, 183, 10.1016/S0002-9149(83)80033-2 Rose, 1962, Comparison of effects of angiotensin and norepinephrine on pulmonary circulation, systemic arteries and veins, and systemic vascular capacity in the dog, Circulation, 25, 247, 10.1161/01.CIR.25.1.247 Cohn, 1966, Relationship of plasma volume changes to resistance and capacitance vessel effects of sympathomimetic amines and angiotensin in man, Clin Sci, 30, 267 Miller, 1976, Pharmacologic mechanisms for left ventricular unloading in clinical congestive heart failure. Differential effects of nitroprusside, phentolamine and nitroglycerin on cardiac function and peripheral circulation, Circ Res, 39, 127, 10.1161/01.RES.39.1.127 Goldberg, 1978, Nitrate therapy of heart failure in valvular heart disease. Importance of resting level of peripheral vascular resistance in determining cardiac output response, Am J Med, 65, 161, 10.1016/0002-9343(78)90705-2 Packer, 1980, Importance of left ventricular chamber size in determining the response to hydralazine in severe chronic heart failure, N Engl J Med, 303, 250, 10.1056/NEJM198007313030503 Massie, 1984, Lack of relationship between short-term hemodynamic effects of captopril and subsequent clinical responses, Circulation, 69, 1135, 10.1161/01.CIR.69.6.1135 Franciosa, 1984, Hemodynamic effects of vasodilators and long-term response in heart failure, J Am Coll Cardiol, 3, 1521, 10.1016/S0735-1097(84)80292-2 Packer, 1979, Hemodynamic and clinical tachyphylaxis to prazosin-mediated afterload reduction in severe chronic congestive heart failure, Circulation, 59, 531, 10.1161/01.CIR.59.3.531 Rubin, 1979, Paradox of improved exercise but not resting hemodynamics with short-term prazosin in chronic heart failure, Am J Cardiol, 43, 810, 10.1016/0002-9149(79)90082-1